CORZ 13F position history: Howard Marks - Oaktree Capital Management
Core Scientific, Inc, as reported in Howard Marks - Oaktree Capital Management’s quarterly 13F filings. See all fund managers holding CORZ.
| Quarter | Activity | Shares | Value | % of portfolio | Reported price | |
|---|---|---|---|---|---|---|
| Q2 2026 | Trimmed | 4,993,708 | $127,788,987 | 3.38% | $25.59 | Filing |
| Q1 2026 | Added | 9,350,708 | $139,886,591 | 3.25% | $14.96 | Filing |
| Q4 2025 | Added | 8,350,708 | $121,586,308 | 2.68% | $14.56 | Filing |
| Q3 2025 | New | 6,400,708 | $114,828,701 | 2.42% | $17.94 | Filing |